Biodesix DSO Ratio 2011-2026 | BDSX

Annual DSO Ratio Biodesix

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
41.7	47.4	41.7	63.5	61.3	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
63.5	41.7	51.1

Quarterly DSO Ratio Biodesix

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
42.2	34.4	41.3	-	45.7	51	54.1	-	33.5	34.7	50.2	-	18.3	15.7	51.8	-	56.3	90.8	53.2	-	152	329	184	-	61.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
329	15.7	73.7

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	31.7	$ 19.89	10.93 %	$ 211 M	China
Agilent Technologies A	63.8	$ 120.39	2.46 %	$ 36.6 B	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
CareDx, Inc CDNA	51.5	$ 17.63	4.75 %	$ 939 M	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	94.7	$ 1.38	-4.83 %	$ 1.84 M	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	49.2	$ 24.37	3.57 %	$ 677 M	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Medpace Holdings MEDP	50.4	$ 520.0	3.74 %	$ 15 B	USA
Charles River Laboratories International CRL	65	$ 179.31	0.54 %	$ 8.89 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Interpace Biosciences IDXG	66.9	$ 2.2	-	$ 9.73 M	USA
Danaher Corporation DHR	55.3	$ 198.61	1.4 %	$ 142 B	USA
Myriad Genetics MYGN	52.3	$ 4.91	6.97 %	$ 455 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
NeoGenomics NEO	77.7	$ 8.35	4.38 %	$ 1.07 B	USA
Illumina ILMN	61.3	$ 130.32	2.65 %	$ 20.7 B	USA
Natera NTRA	81.5	$ 214.64	6.31 %	$ 21.1 B	USA
Fulgent Genetics FLGT	77.4	$ 16.02	4.71 %	$ 484 M	USA
Guardant Health GH	46.1	$ 86.4	5.1 %	$ 10.8 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	275	$ 2.88	1.05 %	$ 93.5 K	USA
Biomerica BMRA	57.7	$ 2.1	0.96 %	$ 4.82 M	USA
Senseonics Holdings SENS	10.3	$ 6.75	0.45 %	$ 282 M	USA
ICON Public Limited Company ICLR	68.5	$ 113.06	2.44 %	$ 9.33 B	Irlanda
Laboratory Corporation of America Holdings LH	52.9	$ 268.87	1.78 %	$ 22.4 B	USA
Soleno Therapeutics SLNO	27	$ 52.62	-0.04 %	$ 2.67 B	USA
Neogen Corporation NEOG	66.6	$ 9.61	5.14 %	$ 2.08 B	USA
Lantheus Holdings LNTH	80.5	$ 82.74	1.31 %	$ 5.58 B	USA
Motus GI Holdings MOTS	77.2	-	-34.28 %	$ 263 K	Israel
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
Quest Diagnostics Incorporated DGX	44.9	$ 194.16	0.65 %	$ 21.6 B	USA
ENDRA Life Sciences NDRA	7.11	$ 4.96	-4.43 %	$ 3.9 M	USA
Neuronetics STIM	48.7	$ 1.43	2.88 %	$ 94.3 M	USA
National Research Corporation NRC	29.4	$ 17.04	1.34 %	$ 381 M	USA